Conference abstract · 10 Dec 2015
EditorialPublished 2011
Pharmaceutical Industry at the Post-Genomic Junction
Subjects
Biochemistry & BiotechnologySimilar by topic
Editorial · Aug 2012
Omics-Based CHO Cell Engineering – Entrance into Post-Genomic Era
Short communication · 1 Aug 2020
Pharmacovigilance 2020: Pancreatic and Thyroid Cancer Related to Exenatide and Liraglutide Treatment: A Post-marketing Analysis of Spontaneous Cases Reported in EudraVigilance Database-Ghanshyam MaliSun Pharmaceutical Industries Ltd.
Commentary · 28 Nov 2023
In the ages of genomics and post-genomics, phytochemistry.
Research article · 15 Jun 2022
Food and Nutritional Research: Post-Genomic Opportunities and Challenges
More from this journal
The newest in Metabolomics:Open Access.
Brief report · 29 Dec 2025
Metabolomics Databases Evolve: Broader Scope, Deeper Insights
Perspective · 29 Dec 2025
Metabolomics: Assessing Environmental Health and Risk
Brief report · 29 Dec 2025
Metabolite Quantification: Accuracy, Standards, Applications
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalMetabolomics:Open Access
- SubjectBiochemistry & Biotechnology
- BylineArticles whose byline prints “Ariel Fernández”

